AzTrials
AzTrials

Calcium Silicate Based Sealer (CSBS)CBSSNCT07865429

Efficiency of Calcium Hydroxide and Calcium Silicate-Based Sealers in Maxillary and Mandibular Molars on Post-Root Canal Pain

A study testing Calcium silicate based sealer in people with Calcium Silicate Based Sealer (CSBS), run by Dow University of Health Sciences at 1 site in Pakistan.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

patients reported at department of Operative dentistry diagnosis section , patients coming to operative department of DIDC-DUHS with the chief complain of moderate to severe pain will be assessed .Complete history of each patient will be obtained along with clinical examination including percussion test, presence of… Read more about this study

Who is it for?
Ages 18 to 45 years
Conditions the study is for
Calcium Silicate Based Sealer (CSBS)
What is being tested?
Calcium silicate based sealer
Could I receive a placebo?
No, everyone receives an active treatment
How many people
96 participants
Where
1 sitePakistan
Study dates
15 Oct 2026to 1 Jun 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Medically healthy patients
  • Age: 18 to 45 years
  • Vital Pulp with moderate to severe pre-operative pain score (VAS score 4-10 on EPT).
  • Symptomatic apical periodontitis
  • Mandibular and maxillary molars.
  • Periapical index (PAI) scores 1-2.

Who cannot join

  • Patients experiencing root resorption
  • Teeth with incomplete root development
  • Calcified canals
  • Severe malocclusion
  • Pregnant or breastfeeding patients
  • Patients who have used analgesics or anti-inflammatory medications within the past 24 hours

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Ayesha Tariq, Recruiting contact

03350287343

ayesha.tariq157@gmail.com

Pakistan1 site
  • Dr Ayesha Tariq

    Karachi, 75100

    Ayesha Tariq, Postgraduate Trainee- FCPS, 03361265165, ayesha.tariq157@gmail.com

    Dr Farah Naz, HOD of Operative and Endodonti

Other trials in Pakistan

About this study

Official title: Effectiveness of Calcium Silicate- and Calcium Hydroxide-Based Sealers on Post-Endodontic Pain

patients reported at department of Operative dentistry diagnosis section , patients coming to operative department of DIDC-DUHS with the chief complain of moderate to severe pain will be assessed .Complete history of each patient will be obtained along with clinical examination including percussion test, presence of swelling, sinus tract and mobility of tooth. Pulp sensitivity will be assessef. Periapical x-ray will be used to evaluate periapical status PAI score. . Following anesthesia, the tooth will be isolated with a rubber dam to maintain a dry operating field. An access cavity will then be prepared. The presence of bleeding within the pulp chamber will be regarded as an indicator of pulp vitality. The (WL) will be established using patency files . An endodontic motor (eight teeth E-connect) will be programmed for root canal instrumentation. Root canals will be irrigated with sodium hypochlorite (NaOCl). Root canals will be dried using paper points, and will take master cone periapical radiograph before final obturation procedure. For the CSBS group (CERASEAL; Meta Biomed Co., Cheongju, Korea), the sealer will be applied and a single cone will be used for obturation. For the CHBS group (Seal apex), the obturation will be completed via cold lateral condensation. The teeth will be restored with composite (LUNA SDI). Single operator will perform the complete procedure. Analgesic ibuprofen 400 mg (Brufen) will be prescribed to the patient in case of severe pain

Being tested
Calcium silicate based sealer

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Calcium silicate based sealerOther

    Root canal sealer used in ENDODONTIC treatment with core material for obturation of root canals

Study groups in NCT07865429
Study groupRoleWhat they receive
Experimental :Calcium silicate based sealerExperimentalRoot canal sealer (CSBS)
Receives: Other: Calcium silicate based sealer
Calcium hydroxide based sealerExperimentalRoot canal sealer (CHBS)
Receives: Other: Calcium silicate based sealer

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Postoperative pain intensity measured using a Visual Analog Scale (VAS)

    Postoperative pain intensity will be assessed using a 10-cm Visual Analog Scale (VAS), ranging from 0 (no pain) to 10 (worst imaginable pain). Participants will record their pain intensity at 6, 24, and 48 hours and at 3 and 7 days after root canal treatment. VAS pain scores at each time point will be recorded and compared between the calcium silicate-based sealer and calcium hydroxide-based sealer groups.

    Measured: 6,24 and 48 hours and after 3 and 7 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Oct 2026
  2. Study start15 Oct 2026 (estimated)
  3. Primary completion1 Mar 2027 (estimated)
  4. Study completion1 Jun 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
96 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07865429
Sponsor's protocol ID
IRB-4095/DUHS/approval/2025/
Acronym
CBSS
Status last verified
Oct 2026
First submitted
25 Mar 2026
Last updated
8 Oct 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: IPS will not be shared outside the study team to ensure patient confidentiality and privacy. Data will be used only for the purposes of this study and will remain restricted to the research team.

Questions about this trial

What is this clinical trial studying?

A study testing Calcium silicate based sealer in people with Calcium Silicate Based Sealer (CSBS), run by Dow University of Health Sciences at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 8 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Ayesha Tariq, Recruiting (03350287343, ayesha.tariq157@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Postoperative pain intensity measured using a Visual Analog Scale (VAS) (time frame: 6,24 and 48 hours and after 3 and 7 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in